Summary
Precision medicine is revolutionizing healthcare by tailoring treatments to each individual’s genetic information and environment. In a world dominated by artificial intelligence, this revolution could be the key to the future of health. However, its development, from the Human Genome Project to global initiatives, raises a crucial question: will it be a technology accessible to all or a privilege for a select few? Through an analysis of cases in the U.S., Europe, and Asia, as well as its economic and sociopolitical impact, this article examines the future of precision medicine and its role in global equity.
A Silent Revolution Amidst the Rise of Artificial Intelligence
They say that in the future, doctors will prescribe treatments tailored to our genes. Hopefully, they’ll also prescribe vacations tailored to our stress levels.
While the world focuses on artificial intelligence (AI), another field is quietly transforming medicine and could directly impact the quality of life of millions: precision medicine. Unlike conventional treatments, which apply general solutions to all patients, precision medicine allows for personalized strategies based on each individual’s genetic information, environment, and lifestyle.
Although the idea of personalized treatments is not new, its modern consolidation came with the decoding of the human genome in 2003. This breakthrough enabled the development of therapies tailored to the unique biology of each patient. As Eric Topol, director of the Scripps Research Translational Institute, notes, “Precision medicine is not just a promise; it is a reality that is transforming how we understand and treat diseases.”
The History and Development of Precision Medicine
The Human Genome Project, completed in 2003, marked a turning point in biomedicine. Thanks to this milestone, genetic variations responsible for diseases were identified, facilitating the development of targeted therapies. Subsequently, advances in genomic sequencing and bioinformatics enabled the integration of this information into clinical practice.
In 2015, former President Barack Obama launched the Precision Medicine Initiative in the U.S. to accelerate research in this field and improve personalized care. Since then, countries such as China, Japan, and Germany have implemented similar programs. Francis Collins, former director of the National Institutes of Health (NIH), explains: “The Human Genome Project was just the beginning. We are now in the era of functional genomics, where we not only read DNA but also understand how it works and how we can intervene.”
Key Advances and Use Cases
United States: Disruptive Innovations
- Gene therapy for rare diseases: In 2024, the U.S. Food and Drug Administration (FDA) approved Casgevy, a CRISPR-based treatment for sickle cell disease and beta-thalassemia.
- NIH’s All of Us program: With over 275 million identified genetic variants, this project aims to revolutionize biomedical research through a diverse and personalized database.
“The All of Us program is a monumental effort to democratize precision medicine. By including people from all backgrounds, we are ensuring that the benefits of this revolution are not limited to a few,” says Joshua Denny, executive director of the program. This inclusive approach is crucial to ensuring that advances benefit historically underrepresented populations.
Europe: Integration Models
- Pharmacogenetics in Spain: The Central University Hospital of Asturias (HUCA) leads a program that adapts medications to patients’ genetic makeup, reducing adverse effects and improving efficacy.
- Radiopharmaceuticals in Germany and France: Novartis and other European pharmaceutical companies are developing treatments with radioactive isotopes to selectively target cancer cells.
“Pharmacogenetics is a clear example of how precision medicine can improve the safety and efficacy of treatments. We are seeing promising results in reducing side effects and personalizing therapies,” explains Ángel Carracedo, Spanish geneticist and director of the Galician Public Foundation of Genomic Medicine. This approach not only saves lives but also reduces long-term costs.
Asia: Large-Scale Innovation
- China and precision medicine: With over 68,000 patent applications in 2020, China leads biomedical innovation in Asia.
- Japan and South Korea: They have registered more than 70,000 combined patents in the past five years, solidifying their role in genetic research and personalized therapy development.
“Asia is at the forefront of innovation in precision medicine, with a particular focus on scalability and the application of emerging technologies such as AI and genetic editing,” says George Church, professor of genetics at Harvard University. This technological leadership could redefine the global healthcare landscape in the coming decades.
Economic Impact and Industry Transformation
The global precision medicine market is estimated at $81 billion in 2024 and could exceed $104 billion by 2029.
The advancement of this discipline will not only drive growth in the pharmaceutical industry but also transform the labor market. Demand for bioinformaticians, geneticists, biomedical engineers, and medical ethics specialists is expected to rise. At the same time, certain traditional medical roles may be displaced or redefined as personalization becomes the norm.
“Precision medicine will not only change how we treat patients but also how we train healthcare professionals. We need a new generation of doctors who understand both genomics and patient care,” states Atul Butte, director of the Institute of Computational Health Sciences at the University of California, San Francisco. This shift could be particularly challenging for countries with less developed healthcare systems.
Reflection: Healthcare for All or an Elite Privilege?
Despite its revolutionary potential, access to precision medicine remains unequal. Yuval Noah Harari warns: “The real challenge is not just developing these technologies but ensuring they are available to everyone.”
Michel Foucault spoke of biopolitics as a way of regulating life through health control. If precision medicine becomes a luxury, it could create a new inequality in healthcare.
This dilemma is particularly relevant in Latin America, where public health systems face budgetary and technological limitations. In Cuba, a historical benchmark in preventive medicine, a lack of resources could hinder the adoption of these technologies. Meanwhile, countries like Brazil and Argentina are exploring public-private partnerships to avoid falling behind in this medical revolution.
Of course, in Latin America, we already have a form of precision medicine: the family remedy passed down for generations. “Drink this tea, and you’ll be fine,” they say. The problem is, sometimes you don’t know if it’s medicine or a mild poison.
Conclusion
Precision medicine represents one of the greatest revolutions in healthcare, but its success will depend on how ethical, economic, and access-related issues are addressed. Will it be a global benefit or a technology restricted to the elites?
Nobel Prize winner in Medicine, Elizabeth Blackburn, concludes: “The future of precision medicine is not written. It is up to us to ensure that it is inclusive and fair.”
Sources
- MedlinePlus. (n.d.). What is precision medicine? Retrieved from https://medlineplus.gov/spanish/genetica/entender/medicinadeprecision/definicion/
- Mordor Intelligence. (n.d.). Precision medicine market size and share analysis. Retrieved from https://www.mordorintelligence.com/industry-reports/precision-medicine-market
- National Institutes of Health (NIH). (n.d.). All of Us Research Program. Retrieved from https://allofus.nih.gov
- Spanish Patent and Trademark Office. (2020). The patent system in 2020: Situation analysis. Retrieved from https://www.oepm.es
- Cadenas SER. (2025, February 19). Research in biomedicine and advanced materials. Retrieved from https://cadenaser.com/andalucia/2025/02/19/la-epsl-participa-en-una-investigacion-internacional
- Harari, Y. N. (2018). 21 Lessons for the 21st Century. Debate.
- Foucault, M. (1976). History of Biopolitics. Siglo XXI.
- World Intellectual Property Organization. (2024). Global patent landscape in precision medicine. Retrieved from https://www.wipo.int/patents/en/precision-medicine
- European Medicines Agency. (2024). Personalized medicine: Regulatory landscape in Europe. Retrieved from https://www.ema.europa.eu/en/medicine-precision
- Topol, E. (2019). Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Basic Books.
- Collins, F. (2021). The Language of Life: DNA and the Revolution in Personalized Medicine. Harper Perennial.
- Ravitsky, V. (2023). Ethics and Equity in Precision Medicine. Oxford University Press.
